Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for circadian rhythm in night shift workers
NCT02108353Phase 3Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of melatonin in circadian rhythm sleep disorder (CRSD), sponsored by University Medical Center Hamburg-Eppendorf. Started Jan 2015; status: completed.
02
Drugs
melatonin
03
Conditions
circadian rhythm sleep disorder (CRSD)
Beyond the preview
Go deeper on NCT02108353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108353.